These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33453249)

  • 41. Mitofusin 2 attenuates the histone acetylation at collagen IV promoter in diabetic nephropathy.
    Mi X; Tang W; Chen X; Liu F; Tang X
    J Mol Endocrinol; 2016 Nov; 57(4):233-249. PubMed ID: 27997345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice.
    Hathaway CK; Gasim AM; Grant R; Chang AS; Kim HS; Madden VJ; Bagnell CR; Jennette JC; Smithies O; Kakoki M
    Proc Natl Acad Sci U S A; 2015 May; 112(18):5815-20. PubMed ID: 25902541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.
    Trohatou O; Tsilibary EF; Charonis A; Iatrou C; Drossopoulou G
    J Cell Mol Med; 2017 Oct; 21(10):2599-2609. PubMed ID: 28664547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
    Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
    J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
    [No Abstract]   [Full Text] [Related]  

  • 45. Protective effect of vanillin on diabetic nephropathy by decreasing advanced glycation end products in rats.
    Zabad IEM; Amin MN; El-Shishtawy MM
    Life Sci; 2019 Dec; 239():117088. PubMed ID: 31759039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB.
    Zhao X; Chen Y; Tan X; Zhang L; Zhang H; Li Z; Liu S; Li R; Lin T; Liao R; Zhang Q; Dong W; Shi W; Liang X
    J Pathol; 2018 Jun; 245(2):235-248. PubMed ID: 29570219
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition).
    Zhuang A; Yap FYT; Borg DJ; McCarthy D; Fotheringham A; Leung S; Penfold SA; Sourris KC; Coughlan MT; Schulz BL; Forbes JM
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00278. PubMed ID: 34277994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy.
    Wan J; Hou X; Zhou Z; Geng J; Tian J; Bai X; Nie J
    Free Radic Biol Med; 2017 Jul; 108():280-299. PubMed ID: 28315733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extract of the aerial parts of Aster koraiensis reduced development of diabetic nephropathy via anti-apoptosis of podocytes in streptozotocin-induced diabetic rats.
    Sohn E; Kim J; Kim CS; Kim YS; Jang DS; Kim JS
    Biochem Biophys Res Commun; 2010 Jan; 391(1):733-8. PubMed ID: 19944074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extract of Rhizoma Polygonum cuspidatum reduces early renal podocyte injury in streptozotocin‑induced diabetic rats and its active compound emodin inhibits methylglyoxal‑mediated glycation of proteins.
    Sohn E; Kim J; Kim CS; Jo K; Kim JS
    Mol Med Rep; 2015 Oct; 12(4):5837-45. PubMed ID: 26299942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A flavonoid fraction purified from Rutaceae aurantiae (Daflon(R)) inhibiting AGE formation, reduces urinary albumin clearance and corrects hypoalbuminemia in normotensive and hypertensive diabetic rats.
    Urios P; Kassab I; Grigorova-Borsos AM; Guillot R; Jacolot P; Tessier F; Peyroux J; Sternberg M
    Diabetes Res Clin Pract; 2014 Sep; 105(3):373-81. PubMed ID: 24956965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth Hormone Induces Transforming Growth Factor-Beta-Induced Protein in Podocytes: Implications for Podocyte Depletion and Proteinuria.
    Chitra PS; Swathi T; Sahay R; Reddy GB; Menon RK; Kumar PA
    J Cell Biochem; 2015 Sep; 116(9):1947-56. PubMed ID: 25740786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
    Yang CW; Vlassara H; Peten EP; He CJ; Striker GE; Striker LJ
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9436-40. PubMed ID: 7937785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
    Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Localization of advanced glycation endproducts in the kidney of experimental diabetic rats.
    Shikata K; Makino H; Sugimoto H; Kushiro M; Ota K; Akiyama K; Araki N; Horiuchi S; Ota Z
    J Diabetes Complications; 1995; 9(4):269-71. PubMed ID: 8573744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus.
    Chuang PY; Dai Y; Liu R; He H; Kretzler M; Jim B; Cohen CD; He JC
    PLoS One; 2011; 6(8):e23566. PubMed ID: 21858169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction.
    Lin CL; Lee PH; Hsu YC; Lei CC; Ko JY; Chuang PC; Huang YT; Wang SY; Wu SL; Chen YS; Chiang WC; Reiser J; Wang FS
    J Am Soc Nephrol; 2014 Aug; 25(8):1698-709. PubMed ID: 24578127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nephrin loss is reduced by grape seed proanthocyanidins in the experimental diabetic nephropathy rat model.
    Li X; Gao Z; Gao H; Li B; Peng T; Jiang B; Yang X; Hu Z
    Mol Med Rep; 2017 Dec; 16(6):9393-9400. PubMed ID: 29152654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
    Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
    Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NADPH oxidase-induced NALP3 inflammasome activation is driven by thioredoxin-interacting protein which contributes to podocyte injury in hyperglycemia.
    Gao P; He FF; Tang H; Lei CT; Chen S; Meng XF; Su H; Zhang C
    J Diabetes Res; 2015; 2015():504761. PubMed ID: 25834832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.